The Patent Finder

Terms ending in 2035

AstraZeneca AB

Every in-force patent on AstraZeneca AB's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,183,020Pharmaceutical Compositions Comprising AZD9291
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 9,815,805Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
In force
 · Low confidence
AstraZeneca ABIn forceLow confidence
US 10,287,258Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
In force
 · Low confidence
AstraZeneca ABIn forceLow confidence
US 10,669,245Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
In force
 · Low confidence
AstraZeneca ABIn forceLow confidence
US 11,117,874Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
In force
 · Low confidence
AstraZeneca ABIn forceLow confidence
US 11,655,221Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
In force
 · Low confidence
AstraZeneca ABIn forceLow confidence
US 11,655,222Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
In force
 · Low confidence
AstraZeneca ABIn forceLow confidence
US 11,655,223Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
In force
 · Low confidence
AstraZeneca ABIn forceLow confidence
US 11,655,224Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
In force
 · Low confidence
AstraZeneca ABIn forceLow confidence
US 11,667,615Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
In force
 · Low confidence
AstraZeneca ABIn forceLow confidence
32 more term ends in 2035 · Pro
10 of 42 patents shown. Soonest term end first, then patent number.
Pro members see all 42.
Upgrade to Pro
35 of these are in force and held by AstraZeneca AB.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited